143 related articles for article (PubMed ID: 22262061)
1. Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma.
Bosch R; Moreno MJ; Dieguez-Gonzalez R; Céspedes MV; Gallardo A; Nomdedeu J; Pavón MA; Espinosa I; Mangues MA; Sierra J; Casanova I; Mangues R
Clin Exp Metastasis; 2012 Apr; 29(4):339-47. PubMed ID: 22262061
[TBL] [Abstract][Full Text] [Related]
2. A novel orally available inhibitor of focal adhesion signaling increases survival in a xenograft model of diffuse large B-cell lymphoma with central nervous system involvement.
Bosch R; Moreno MJ; Dieguez-Gonzalez R; Céspedes MV; Gallardo A; Trias M; Grañena A; Sierra J; Casanova I; Mangues R
Haematologica; 2013 Aug; 98(8):1242-9. PubMed ID: 23716554
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor.
Levi E; Zhang L; Aboukameel A; Rishi S; Mohammad RM; Polin L; Hatfield JS; Rishi AK
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1401-13. PubMed ID: 20809119
[TBL] [Abstract][Full Text] [Related]
4. Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy.
Mohammad RM; Al-Katib A; Aboukameel A; Doerge DR; Sarkar F; Kucuk O
Mol Cancer Ther; 2003 Dec; 2(12):1361-8. PubMed ID: 14707277
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.
Moreno MJ; Bosch R; Dieguez-Gonzalez R; Novelli S; Mozos A; Gallardo A; Pavón MÁ; Céspedes MV; Grañena A; Alcoceba M; Blanco O; Gonzalez-Díaz M; Sierra J; Mangues R; Casanova I
J Pathol; 2015 Feb; 235(3):445-55. PubMed ID: 25231113
[TBL] [Abstract][Full Text] [Related]
6. Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-X(L) [(-)-gossypol] against diffuse large cell lymphoma.
Mohammad RM; Wang S; Aboukameel A; Chen B; Wu X; Chen J; Al-Katib A
Mol Cancer Ther; 2005 Jan; 4(1):13-21. PubMed ID: 15657349
[TBL] [Abstract][Full Text] [Related]
7. MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma.
Shi JQ; Lasky K; Shinde V; Stringer B; Qian MG; Liao D; Liu R; Driscoll D; Nestor MT; Amidon BS; Rao Y; Duffey MO; Manfredi MG; Vos TJ; D' Amore N; Hyer ML
Mol Cancer Ther; 2012 Sep; 11(9):2045-53. PubMed ID: 22609854
[TBL] [Abstract][Full Text] [Related]
8. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
Rombouts WJ; Martens AC; Ploemacher RE
Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
Mohammad R; Abubakr Y; Dan M; Aboukameel A; Chow C; Mohamed A; Hamdy N; Al-Katib A
Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and characterization of a nude mice model of human diffuse large B-cell lymphoma].
Yu BH; Zhou XY; Zhang TC; Zhang TM; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):246-50. PubMed ID: 21615998
[TBL] [Abstract][Full Text] [Related]
11. Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.
Al-Katib AM; Smith MR; Kamanda WS; Pettit GR; Hamdan M; Mohamed AN; Chelladurai B; Mohammad RM
Clin Cancer Res; 1998 May; 4(5):1305-14. PubMed ID: 9607591
[TBL] [Abstract][Full Text] [Related]
12. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.
Hazari S; Hefler HJ; Chandra PK; Poat B; Gunduz F; Ooms T; Wu T; Balart LA; Dash S
World J Gastroenterol; 2011 Jan; 17(3):300-12. PubMed ID: 21253388
[TBL] [Abstract][Full Text] [Related]
14. Novel targeted mtLivin nanoparticles treatment for disseminated diffuse large B-cell lymphoma.
Abd-Elrahman I; Nassar T; Khairi N; Perlman R; Benita S; Ben Yehuda D
Oncogene; 2021 Jan; 40(2):334-344. PubMed ID: 33128043
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studies.
Dias JNR; André AS; Aguiar SI; Ministro J; Oliveira J; Peleteiro MC; Rütgen B; Gano L; Correia JDG; Oliveira SS; Goncalves J; Gil S; Tavares L; Aires-da-Silva F
PLoS One; 2018; 13(12):e0208147. PubMed ID: 30592723
[TBL] [Abstract][Full Text] [Related]
16. Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.
Al-Katib AM; Aboukameel A; Mohammad R; Bissery MC; Zuany-Amorim C
Clin Cancer Res; 2009 Jun; 15(12):4038-45. PubMed ID: 19509168
[TBL] [Abstract][Full Text] [Related]
17. Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine.
Mohammad RM; Limvarapuss C; Hamdy N; Dutcher BS; Beck FW; Wall NR; Al-Katib AM
Int J Oncol; 1999 May; 14(5):945-50. PubMed ID: 10200346
[TBL] [Abstract][Full Text] [Related]
18. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc.
Cui W; Zheng S; Li X; Ma Y; Sang W; Liu M; Zhang W; Zhou X
Tumour Biol; 2016 Sep; 37(9):12767-12777. PubMed ID: 27448819
[TBL] [Abstract][Full Text] [Related]
19. Use of a murine xenograft model for canine transmissible venereal tumor.
Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
[TBL] [Abstract][Full Text] [Related]
20. [SUDHL-4 cell culture in vitro and establishment of mouse tumor model].
Wang YQ; Huo HJ; Lu LL; Xu M; Zhu JP; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):329-34. PubMed ID: 22541092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
